Natural Health Trends (NHTC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 6, 2025, to elect five directors and ratify the appointment of CBIZ CPAs P.C. as the independent auditor for 2025.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact.
Shareholders of record as of March 14, 2025, are eligible to vote on the proposals.
Voting matters and shareholder proposals
Shareholders will vote on the election of five directors and the ratification of CBIZ CPAs P.C. as the independent auditor.
Board recommends voting for all director nominees and for the auditor ratification.
Shareholder proposals for the 2026 meeting must be submitted by November 24, 2025, with specific advance notice requirements for nominations and other business.
Board of directors and corporate governance
Board expanded to five members in July 2024; Lucy N. Nduati was elected as a new director.
Three directors are considered independent under Nasdaq rules; all committee members are independent.
Board met four times in 2024; all directors attended at least 75% of meetings.
Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and responsibilities.
Board encourages diversity in director nominations and considers a range of factors including experience, skills, and background.
Communication channels are available for shareholders to contact the board or committees.
Insider trading and hedging by employees and directors are prohibited; a Code of Ethics is in place.
Latest events from Natural Health Trends
- Shareholders will vote on director elections, a new equity plan, and auditor ratification.NHTC
Proxy filing24 Mar 2026 - Director elections, equity plan, and auditor ratification up for vote at May 2026 meeting.NHTC
Proxy filing24 Mar 2026 - Annual meeting to elect directors, approve equity plan, and ratify auditor, with focus on governance.NHTC
Proxy filing24 Mar 2026 - Q4 revenue up 3% sequentially; $1.5M in annual savings and $0.10 dividend declared.NHTC
Q4 20254 Feb 2026 - Flat Q2 sales, improved profit, and Hong Kong's first sales growth since Q1 2023.NHTC
Q2 20242 Feb 2026 - Q3 2024 sales up 1% to $10.7M, net income $35K, and $0.20 dividend declared.NHTC
Q3 202417 Jan 2026 - Q4 2024 revenue flat, Greater China up 7%, net income $176K, $9.2M dividends paid.NHTC
Q4 202424 Dec 2025 - Revenue down 2% year-over-year, orders up 9%, $0.20 dividend declared, trade risks persist.NHTC
Q1 202523 Dec 2025 - Vote on director elections and auditor ratification at the May 2025 annual meeting.NHTC
Proxy Filing2 Dec 2025